USNA Stock Cash Flow Statements

USANA Health Sciences Quarterly Cash Flow Statements Chart

Quarterly

Annual

Operating Cash Flow

Investing Cash Flow

Financing Cash Flow

Free Cash Flow

Capital Expenditure

USANA Health Sciences Quarterly Cash Flow Statements Table

Quarterly

Annual

Unit: USD	2025-06-28	2025-03-29	2024-12-28	2024-09-28	2024-06-29	2024-03-30	2023-12-30	2023-09-30	2023-07-01	2023-04-01	2022-12-31	2022-10-01	2022-07-02	2022-04-02	2021-10-02	2021-07-03	2021-04-03	2021-01-01	2020-09-26	2020-06-27	2020-03-28	2019-12-28	2019-09-29	2019-06-30	2019-03-31	2018-09-30	2018-07-01	2018-04-01	2017-10-01	2017-07-02	2017-04-02	2016-10-03	2016-07-04	2016-04-04	2015-09-27	2015-06-28	2015-03-29	2014-09-28	2014-06-29	2014-03-30	2013-09-29	2013-06-30	2013-03-31	2012-10-01	2012-07-02	2012-04-02	2011-10-02	2011-07-03	2011-04-03	2010-10-03	2010-07-04	2010-04-04	2010-01-01	2009-09-27	2009-06-28	2009-03-29	2008-09-29	2008-06-30	2008-03-31	2007-09-30	2007-07-01	2007-04-01	2006-12-30	2006-10-01	2006-07-02	2006-04-02	2005-12-31	2005-10-02	2005-07-03	2005-04-03	2004-09-27	2004-06-28	2004-03-29	2004-01-01	2003-09-28	2003-06-29	2003-03-30	2002-12-28	2002-09-29	2002-06-30	2002-03-31	2001-12-29	2001-09-30

cash flows from operating activities
net earnings	10,444,000	9,290,000	4,484,000	10,607,000	10,432,000	16,537,000	16,766,000	11,347,000	17,292,000	18,383,000	12,795,000	14,929,000	19,157,000	22,469,000	27,330,000	38,234,000	30,621,000	31,470,000	30,506,000	27,977,000	26,552,000	30,754,000	24,222,000	21,378,000	24,172,000	31,040,000	33,907,000	28,946,000	23,769,000	23,259,000	21,358,000	30,098,000	25,762,000	22,299,000	25,609,000	25,416,000	19,680,000	19,498,000	19,301,000	16,537,000	16,753,000	24,210,000	17,779,000	17,490,000	16,745,000	13,751,000	12,385,000	13,856,000	11,350,000	12,849,000	10,770,000	9,641,000	22,302,000	7,912,000	8,791,000	6,646,000	8,139,000	10,148,000	7,547,000	11,258,000	11,314,000	11,686,000	-30,085,734	10,223,000	10,344,000	9,560,000	-28,474,006	10,042,000	9,543,000	8,928,000	7,996,000	7,413,000	6,213,000	16,797,000	6,056,000	4,349,000	3,575,000	3,305,000	2,343,000	1,738,000	1,117,000	648,000	586,000
adjustments to reconcile net earnings to net cash from operating activities
depreciation and amortization	7,743,000	8,339,000	3,999,000	3,569,000	3,813,000	3,158,000	2,912,000	3,271,000	3,220,000	3,299,000	3,292,000	3,473,000	3,349,000	3,279,000	3,243,000	3,280,000	3,231,000	2,523,000	3,469,000	3,550,000	3,494,000	3,556,000	3,533,000	3,788,000	3,866,000	4,049,000	4,154,000	4,531,000	4,131,000	4,200,000	3,466,000	3,176,000	3,234,000	3,520,000	2,654,000	2,293,000	2,337,000	2,277,000	2,197,000	2,211,000	2,239,000	2,328,000	2,303,000	2,198,000	2,214,000	2,196,000	2,115,000	2,110,000	2,136,000	2,018,000	1,819,000	1,804,000	2,604,000	1,743,000	1,743,000	1,826,000	1,723,000	1,562,000	1,609,000	1,142,000	1,171,000	1,286,000	-4,243,438	1,325,000	1,460,000	1,464,000	-4,347,096	1,529,000	1,476,000	1,348,000	1,175,000	1,229,000	1,026,000	2,001,000	1,000,000	924,000	915,000	1,021,000	1,021,000	1,036,000	1,059,000	1,115,000	1,047,000
right-of-use asset reduction	1,861,000	1,906,000
(gain) loss on sale of property and equipment			0	-16,000	-388,000	405,000	-2,000	24,000			3,000	64,000	77,000	-3,000	0	-2,000	47,000	-84,000	29,000			47,000	11,000	3,000	23,000	27,000	-5,000	1,782,000				15,000	1,000	39,000	-27,000	3,000	25,000	15,000	12,000	4,000															0	20,000											-6,990	2,000															9,000
equity-based compensation expense	3,622,000	2,880,000	3,613,000	3,542,000	3,734,000	3,669,000	3,643,000	3,670,000	3,674,000	3,608,000	3,516,000	3,076,000	3,556,000	3,183,000	3,454,000	3,845,000	3,740,000	3,779,000	3,528,000	3,597,000	3,394,000	2,857,000	4,083,000	4,769,000	3,832,000	3,968,000	3,253,000	3,805,000	3,709,000	3,804,000	4,198,000	4,542,000	4,812,000	4,609,000	2,564,000	2,178,000	2,210,000	1,858,000	2,235,000	1,836,000	1,686,000	2,058,000	2,369,000	2,566,000	2,752,000	2,866,000	2,937,000	1,567,000	3,235,000	2,967,000	2,184,000	1,956,000	3,490,000	2,298,000	2,104,000	2,514,000	2,076,000	1,370,000	1,488,000	1,566,000	1,629,000	1,591,000	-3,463,211	1,316,000	1,205,000	947,000
deferred income taxes	-7,840,000	1,355,000	-2,697,000	871,000	-7,465,000	2,547,000	1,469,000	808,000	-8,583,000	3,557,000	1,131,000	-1,489,000	-10,492,000	3,667,000	3,172,000	-8,743,000	2,968,000	1,653,000	703,000	-9,937,000	4,611,000	6,999,000	88,000	-13,770,000	3,048,000			3,102,000			1,380,000										353,000																												-178,000	234,000		66,000	108,000									331,000	609,000
inventory write-down	834,000	1,211,000	2,000	377,000	578,000	934,000
changes in operating assets and liabilities:
inventories	-8,067,000	-4,921,000	1,676,000	692,000	-2,685,000	-1,801,000	-1,050,000	1,269,000	-72,000	2,206,000	7,638,000	5,704,000	8,489,000	48,000	-8,354,000	-1,647,000	1,393,000	-1,643,000	-6,908,000	-7,103,000	5,153,000	9,129,000	9,887,000															1,922,000	2,989,000	45,000				996,000	1,281,000	2,185,000			373,000											1,489,000	-217,000	243,000			296,000	44,000											204,000
prepaid expenses and other assets	-208,000	-252,000	-4,118,000	1,022,000	5,333,000	-5,108,000	-5,006,000	3,130,000	7,191,000	-5,205,000	-4,464,000	4,232,000	-1,207,000	-1,865,000	4,361,000	1,249,000	-3,960,000	4,928,000	-2,369,000	-628,000	-4,262,000	-882,000	4,737,000	1,854,000	1,480,000				1,572,000	1,024,000	3,756,000			1,033,000			890,000						6,136,000			414,000	1,954,000	-1,612,000	5,721,000	-966,000	69,000	927,000		1,417,000	-514,000	2,873,000	-2,139,000	21,000	2,270,000		-1,531,000	1,637,000
accounts payable	3,838,000	1,975,000	1,775,000	266,000	-1,592,000	-1,718,000	1,929,000	-1,186,000	-925,000	-246,000	86,000	969,000	-1,558,000	-2,153,000	807,000	1,869,000	-6,899,000	-6,751,000	3,299,000	-946,000	-174,000	3,083,000	-2,627,000	-371,000	1,750,000	2,309,000	-103,000	649,000			263,000	517,000			703,000	376,000	789,000				893,000	-942,000	1,097,000				700,000	474,000	1,440,000	-1,271,000						780,000	1,310,000	1,096,000	609,000				-3,948,626	2,574,000	679,000	700,000				42,000			75,000		-139,000	1,459,000	271,000	-340,000	-10,000				226,000
other liabilities	-38,000	-6,301,000	-4,834,000	6,614,000	-5,659,000	-2,866,000	802,000	-1,987,000	-14,155,000	-14,694,000	14,506,000	-3,785,000	-8,536,000	-11,251,000	1,234,000	-1,205,000	-13,741,000	-29,812,000	14,681,000	13,912,000	-10,237,000	-1,972,000	4,262,000			16,781,000						-554,000			1,784,000	3,105,000	3,960,000				10,960,000			-815,000	5,542,000	2,472,000				3,818,000	-1,005,000	3,324,000					3,711,000
net cash from operating activities	12,218,000	15,482,000	5,785,000	29,534,000	7,990,000	17,683,000	26,023,000	22,234,000	9,551,000	12,833,000	40,463,000	29,125,000	14,613,000	19,701,000	37,488,000	39,158,000	19,659,000	8,741,000	49,062,000	32,638,000	30,786,000	55,740,000	50,314,000	15,158,000	5,521,000	54,500,000	37,675,000	19,518,000	13,037,000	53,712,000	1,901,000	33,763,000	34,506,000	13,471,000	28,350,000	22,606,000	23,561,000	36,145,000	28,781,000	2,469,000	17,297,000	26,991,000	20,305,000	19,677,000	21,303,000	22,643,000	22,067,000	13,856,000	17,545,000	20,912,000	10,265,000	15,062,000	45,580,000	14,064,000			12,925,000	16,135,000	9,060,000	11,543,000	16,361,000	16,238,000	-44,978,480	14,801,000	14,861,000	15,377,000	-32,716,982	10,801,000	14,427,000	7,537,000	14,521,000	9,075,000	7,795,000	12,514,000	8,620,000	9,910,000	7,139,000	4,150,000	4,917,000	3,648,000	3,228,000	1,178,000	2,594,000
capex	-4,995,000	-2,772,000	-1,802,000	-2,355,000	-2,697,000	-3,118,000	-7,324,000	-202,000	-3,845,000	-1,739,000	-3,285,000	-4,364,000	-1,043,000	-1,504,000	-6,672,000	-1,335,000	-1,358,000	816,000	-2,988,000	-3,550,000	-6,658,000	-4,422,000	-4,678,000	408,000	251,000	-101,000	-8,000	159,000	177,000	0	0	-570,000	-322,000	2,655,000	1,757,000	-761,000	910,000	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0			0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
free cash flows	7,223,000	12,710,000	3,983,000	27,179,000	5,293,000	14,565,000	18,699,000	22,032,000	5,706,000	11,094,000	37,178,000	24,761,000	13,570,000	18,197,000	30,816,000	37,823,000	18,301,000	9,557,000	46,074,000	29,088,000	24,128,000	51,318,000	45,636,000	15,566,000	5,772,000	54,399,000	37,667,000	19,677,000	13,214,000	53,712,000	1,901,000	33,193,000	34,184,000	16,126,000	30,107,000	21,845,000	24,471,000	36,145,000	28,781,000	2,469,000	17,297,000	26,991,000	20,305,000	19,677,000	21,303,000	22,643,000	22,067,000	13,856,000	17,545,000	20,912,000	10,265,000	15,062,000	45,580,000	14,064,000			12,925,000	16,135,000	9,060,000	11,543,000	16,361,000	16,238,000	-44,978,480	14,801,000	14,861,000	15,377,000	-32,716,982	10,801,000	14,427,000	7,537,000	14,521,000	9,075,000	7,795,000	12,514,000	8,620,000	9,910,000	7,139,000	4,150,000	4,917,000	3,648,000	3,228,000	1,178,000	2,594,000
cash flows from investing activities
proceeds from the settlement of net investment hedges			0	0			0	0			0	0							0			0	0			0
payments for net investment hedge	0	-1,072,000	0	0	0	-870,000	0	0	0	-1,271,000					0	0	-1,555,000	-466,000	0	0	-1,089,000	0	0
proceeds from acquisition working capital adjustment
proceeds from sale of property and equipment			0	61,000	0	3,000	2,000	0			3,000	1,000	0	3,000	0	2,000	13,000					6,000	5,000	0	6,000	0	346,000	35,000	5,000	1,000	10,000	2,000						2,000	2,000	6,000	32,000	12,000	3,000	0	97,000	51,000	0			28,000	3,000	1,000	-804,000	836,000
purchases of property and equipment	-5,027,000	-2,803,000	-1,802,000	-2,399,000	-2,671,000	-3,201,000	-7,324,000	-1,454,000	-3,609,000	-2,107,000	-3,285,000	-3,580,000	-1,746,000	-1,789,000	-6,464,000	-1,549,000	-1,597,000	847,000	-2,789,000	-3,555,000	-7,266,000	-5,197,000	-4,242,000
net cash from investing activities	-4,162,000	-3,875,000	-205,138,000	-2,338,000	-1,546,000	-4,068,000	-7,322,000	-1,454,000	179,000	-3,378,000	-3,282,000	-3,579,000	-3,723,000	-1,786,000	-6,452,000	-1,494,000	-3,088,000	-1,659,000	-2,732,000	-1,526,000	-8,270,000	-5,105,000	-1,185,000	21,275,000	32,509,000															1,811,000
cash flows from financing activities
repurchase of common stock	-15,207,000	-12,300,000	0	0	0	-9,444,000	0				0	0	0	-25,382,000	-46,771,000	-31,545,000	-67,610,000	-120,808,000	0	0	-57,029,000	0	-92,377,000
borrowings on line of credit			22,998,000	-2,000	154,000	537,000	792,000	0			0	500,000	500,000	10,000,000					0			0	0	0	5,000,000				0			1,200,000	1,500,000	71,000,000										1,249,000									-24,560,000	6,370,000	21,790,000	27,550,000	43,900,000
payments on line of credit			6,000	3,000			0	0			0	-500,000							0			0	0
payments related to tax withholding for net-share settled equity awards	-24,000	-2,167,000	-74,000	-79,000	-31,000	-3,039,000	-134,000	-42,000	-55,000	-2,861,000	-150,000	-44,000	-301,000	-4,211,000	-60,000	-116,000	-2,865,000	-1,634,000	-43,000	-75,000	-1,823,000	-305,000	-34,000
distributions to redeemable noncontrolling interest
net cash from financing activities	-38,610,000	-14,467,000	22,930,000	-78,000	-1,353,000	-11,946,000	658,000	-11,641,000	-55,000	-3,199,000	-150,000	-44,000	-10,301,000	-19,593,000	-46,831,000	-31,661,000	-70,475,000	-122,442,000	-43,000	-75,000	-58,852,000	-305,000	-92,476,000											1,140,000	4,003,000	4,826,000	910,000			1,856,000						176,000													1,443,000							951,000				1,537,000
effect of exchange rate changes on cash, cash equivalents, and restricted cash	2,313,000	719,000	-6,810,000	5,448,000	-1,022,000	-3,809,000	4,064,000	-2,257,000	-5,100,000	790,000	3,925,000	-9,167,000	-8,132,000	-403,000	-866,000	2,477,000	-1,962,000	-584,000	4,867,000	2,241,000	-4,436,000
net increase in cash, cash equivalents, and restricted cash	-28,241,000	-2,141,000	-183,233,000	32,566,000	4,069,000	-2,140,000	23,423,000	6,882,000	4,575,000	7,046,000	40,956,000	16,335,000	-7,543,000	-2,081,000	-16,661,000	8,480,000	-55,866,000	-115,944,000	51,154,000	33,278,000	-40,772,000
cash, cash equivalents, and restricted cash at beginning of period	0	184,508,000	0	0	0	333,246,000	0	0	0	291,320,000	0	0	0	243,653,000	0	0	315,937,000	78,249,000	0	0	237,688,000
cash, cash equivalents, and restricted cash at end of period	-28,241,000	182,367,000	-183,233,000	32,566,000	4,069,000	331,106,000	23,423,000	6,882,000	4,575,000	298,366,000	40,956,000	16,335,000	-7,543,000	241,572,000	-16,661,000	8,480,000	260,071,000	-37,695,000	51,154,000	33,278,000	196,916,000	52,132,000	-48,709,000	6,244,000	228,021,000	-16,685,000	-10,253,000	269,709,000
reconciliation of cash, cash equivalents, and restricted cash to the consolidated balance sheets
cash and cash equivalents	-28,275,000	179,613,000		32,466,000	4,087,000	328,336,000	23,339,000	6,898,000	4,729,000	295,454,000	41,541,000	16,509,000	-7,383,000	237,753,000	-16,673,000	8,404,000	256,964,000	-38,586,000	51,050,000	33,270,000	194,098,000
restricted cash included in other assets	34,000	2,754,000		100,000	-18,000	2,770,000	84,000	-16,000	-154,000	2,912,000	-585,000	-174,000	-160,000	3,819,000	12,000	44,000	3,046,000	891,000	104,000	8,000	2,818,000	50,000	-104,000	-68,000	2,980,000	-110,000	-160,000	3,182,000
total cash, cash equivalents, and restricted cash	-28,241,000	182,367,000		32,566,000	4,069,000	331,106,000		6,882,000	4,575,000	298,366,000	40,956,000	16,335,000	-7,543,000	241,572,000	-16,661,000	8,480,000	260,071,000	-37,695,000	51,154,000	33,278,000	196,916,000	52,132,000	-48,709,000	6,244,000	228,021,000	-16,685,000	-10,253,000	269,709,000
supplemental disclosures of cash flow information
cash paid during the period for:
interest	610,000	52,000		1,000	48,000	24,000		2,000	1,000	2,000		2,000	40,000	5,000	3,000	2,000	3,000	-1,546,000	1,357,000	197,000	2,000	1,000	3,000	2,000	5,000	1,000	2,000	2,000	3,000	4,000	2,000	0	170,000	147,000	4,000			5,000	0	6,000							1,000	2,000	7,000	30,000	6,000	26,000								763,000	200,000	1,000	-4,994	-3,000			-7,989	5,000							0	2,000	63,000	66,000	75,000	98,000	117,000		252,000
income taxes	17,535,000	7,767,000		6,693,000	17,472,000	9,100,000		7,141,000	18,635,000	10,182,000		7,681,000	23,176,000	8,347,000	10,274,000	25,268,000	13,523,000	15,735,000	12,923,000	21,172,000	9,694,000	9,248,000	10,517,000	24,986,000	10,163,000	12,712,000	27,037,000	19,495,000	19,603,000	10,842,000	10,087,000	12,971,000	19,556,000	8,587,000	3,940,000	11,982,000	2,996,000	1,753,000	9,176,000	787,000	4,514,000	19,939,000	1,101,000	11,715,000	12,552,000	741,000	5,798,000	13,139,000	344,000	6,069,000	11,864,000	649,000	3,754,000	5,382,000	12,176,000	316,000	6,274,000	8,532,000	1,416,000	8,129,000	10,936,000	407,000	-15,768,960	5,297,000	9,473,000	1,018,000	-10,986,844	5,058,000	5,240,000	704,000	553,000	5,374,000	353,000	7,340,000	477,000	1,033,000	134,000	367,000	1,003,000	1,745,000	99,000		241,000
cash received during the period for:
income tax refund	7,000	38,000		2,000				484,000	163,000	517,000		53,000	18,000	25,000				-79,000	228,000			110,000	263,000	74,000	5,095,000	385,000	2,017,000	49,000	0	0	4,700,000
non-cash investing and financing activities:
right-of-use assets obtained in exchange for lease obligations	2,324,000	3,938,000		9,302,000	446,000	167,000		275,000	2,882,000	1,806,000		637,000	4,182,000	289,000	820,000	299,000	829,000	1,547,000	2,624,000	-763,000	1,914,000	7,386,000	2,946,000	2,640,000	20,286,000
accrued purchases of property and equipment	32,000	31,000		44,000	-26,000	83,000		1,252,000	-236,000	368,000		-784,000	703,000	285,000	-208,000	214,000	239,000	-31,000	-199,000	5,000	608,000	775,000	-436,000	408,000	251,000	-101,000	-8,000	159,000	177,000			-570,000	-322,000	2,655,000	1,757,000	-761,000	910,000
accrued excise tax for repurchase of common stock	151,000	80,000		0	0	39,000
changes in operating assets and liabilities, net of acquisitions:
payments to acquire businesses, net of cash acquired
payments for contingent consideration							0	0	0	-338,000
right-of-use asset amortization				1,990,000	1,889,000	1,926,000	1,959,000	1,888,000	1,921,000	1,925,000	1,960,000	1,952,000	1,778,000	2,327,000	2,241,000	2,278,000	2,259,000	2,678,000	2,124,000	2,100,000	2,255,000	2,169,000	2,118,000	1,954,000	2,023,000
receipts on notes receivable															12,000	53,000	51,000	-120,000	57,000	94,000	85,000	86,000	53,000	37,000	55,000	41,000	4,459,000	301,000	0	152,000	107,000	162,000	394,000	49,000																				61,000	44,000	64,000	504,000	20,000	37,000	31,000	30,000	30,000
payments to acquire businesses
contingent consideration given to acquire businesses
(gain) loss on impairment on other assets
payments for investment in equity securities
payments for debt issuance costs
restricted cash included in prepaid expenses and other current assets															0	32,000	61,000									0	-222,000	330,000
payments to acquire assets												0
contingent consideration given to acquire assets												0
unsettled trades for repurchase of common stock																	1,844,000
maturities of investment securities held-to-maturity																						0	2,999,000
non-cash change in right-of-use assets
reconciliation of cash, cash equivalents, and restricted cash to the condensed consolidated balance sheets
(gain) loss on impairment on note receivable
purchases of investment securities held-to-maturity
proceeds from disgorgement of short-swing stock profits																										0
non-cash operating activities:
non-cash investing activities:
credits on notes receivable																													221,000	0	191,000	290,000	347,000	505,000	410,000	1,000	55,000
money market funds included in cash equivalents
foreign currency contracts included in other current liabilities
deferred debt issuance costs
effect of exchange rate changes on cash, cash equivalents and restricted cash																							-5,362,000	-2,331,000	4,170,000			5,519,000
net increase in cash, cash equivalents and restricted cash																							-48,709,000	6,244,000	10,787,000		-10,253,000	19,174,000
cash, cash equivalents, and restricted cash, at beginning of period																							0	0	217,234,000	0	0	250,535,000
cash and equivalents																							-48,605,000	6,312,000	225,041,000	-16,575,000	-9,871,000	266,197,000
leases
assets
rou operating lease assets																							109,000
total rou assets																							109,000
liabilities
current:
operating lease liabilities																							376,000
non-current:
total lease liabilities																							300,000
maturities of investment securities																									36,685,000													3,374,000	3,436,000	5,701,000
impairment on notes receivable
additions to notes receivable
effect of exchange rate changes on cash and cash equivalents																													1,662,000	2,768,000	1,909,000			1,605,000			361,000							369,000	-79,000	168,000		252,000	114,000			189,000	497,000	359,000				6,000	127,000			3,000	-71,942			85,000							279,000	-335,000	716,000	-20,000	144,000
net increase in cash and cash equivalents																													-37,620,000	53,045,000	546,000			7,291,000	23,266,000	22,360,000	17,443,000			5,390,000	19,293,000	25,009,000	208,000	11,063,000	-5,626,000	20,811,000	11,373,000	-7,774,000	8,496,000	-5,499,000	6,904,000	7,865,000							4,701,000			5,467,000	-10,381,550			14,926,000		10,893,000	-1,605,000	6,966,000					-3,629,000			412,000	1,802,000	1,203,000	804,000		940,000
cash and cash equivalents, beginning of period																													0	0	175,774,000	0	0	143,210,000	0	0	111,126,000	0	0	137,343,000	0	0	70,839,000	0	0	50,353,000	0	0	24,222,000	0	0	13,658,000		0			0	0	12,865,000	0	0	27,029,000		0	0	10,579,000		0	0	15,067,000	0	0	18,965,000		0	0	6,686,000
cash and cash equivalents, end of period																													-37,620,000	53,045,000	176,320,000	22,145,000	-38,103,000	150,501,000	23,266,000	22,360,000	128,569,000	-30,529,000	-24,466,000	142,733,000	19,293,000	25,009,000	71,047,000	11,063,000	-5,626,000	71,164,000	11,373,000	-7,774,000	32,718,000	-5,499,000	6,904,000	21,523,000		2,095,000			3,717,000	-7,584,000	17,566,000	1,842,000	-22,620,000	32,496,000		11,804,000	-16,332,000	25,505,000		10,893,000	-1,605,000	22,033,000	7,647,000	-1,063,000	14,861,000		-3,629,000	8,479,000	5,485,000
excess tax benefits from equity-based payment arrangements																																			4,003,000	4,826,000	910,000	609,000	1,531,000	1,856,000	5,836,000	1,549,000	185,000	2,399,000	204,000	176,000	0			731,000	6,000	55,000	2,438,000
income tax payable related to tax benefit from equity award activity																																			3,851,000	4,826,000	910,000
non-cash financing activities:
proceeds from equity awards exercised																																									0			270,000			0			4,581,000	0	59,000	11,929,000				194,000			884,000	4,000	2,197,000				739,000
common stock awarded to associates																																																												0	-3,000	50,000	-100,899
increase in notes receivable
total adjustments																																										2,781,000	2,526,000	2,187,000	4,558,000	8,892,000	9,682,000	0	6,195,000	8,063,000	-505,000	5,421,000					4,786,000	5,987,000	1,513,000	285,000	5,047,000	4,552,000	-14,892,746	4,578,000	4,517,000	5,817,000	-4,242,976	759,000			6,525,000	1,662,000	1,582,000	-4,283,000	2,564,000	5,561,000	3,564,000	845,000	2,574,000	1,910,000	2,111,000	530,000	2,008,000
loss on sale of property and equipment																																															35,000				-1,000	8,000																										91,000	-3,000	-7,000	18,000
inventory valuation																																															313,000	308,000	267,000
acquisitions, net of cash acquired
non-cash financing activities
common stock issued in connection with acquisitions
excess tax benefit from equity-based payment arrangements																																																	35,000								1,197,000	-85,000	1,113,000	227,000	60,000	784,000		1,277,000	620,000	212,000
gain on sale of property and equipment
benefit from inventory valuation																																																		388,000	253,000	348,000		446,000	34,000	300,000	300,000	200,000	200,000	282,000	241,000	450,000													-119,000
acquisition, net of cash acquired
cash and cash equivalents, beginning of year																																																								13,281,000
cash and cash equivalents, end of year																																																								9,747,000
cash paid during the year for:
interest, net of amount capitalized																																																					-404,000	92,000	133,000	278,000	-56,000	193,000	178,000
net decrease in cash and cash equivalents
increase in cash and cash equivalents
(gain) loss on disposition of property and equipment
proceeds from the sale of property and equipment																																																									17,000	-3,000	122,000	746,000	4,000	19,000						13,000			8,000	19,000	2,000		7,000	5,000	35,000		14,000	15,000	8,000		41,000
write-down of assets held for sale
proceeds from stock options exercised																																																											330,000								-2,687,039	1,139,000	14,000	1,537,000
other current liabilities																																																												-968,000	2,778,000	3,389,000	-7,175,160	3,384,000	507,000	3,298,000	-5,416,937	-678,000	2,407,000	3,698,000	4,499,000	299,000	1,389,000	-2,378,000	5,071,000	3,702,000	1,965,000	1,264,000	1,025,000	447,000	1,946,000	-593,000	78,000
increases in notes receivable
retirement of common stock
loss on disposition of property and equipment																																																													41,000	32,000
increase in line of credit
allowance for inventory valuation																																																															-1,810,654	123,000	894,000	796,000	-1,294,170	1,253,000	-601,000	644,000	620,000
proceeds from exercise of equity-based awards																																																																1,737,000
redemption of common stock
principal payments of long-term debt
decrease in line of credit
payments on capital lease obligations
non-cash activities
in february 2004, the company acquired fmg productions, llc for 2,137 in cash, which included 77 for professional fees directly associated with the acquisition.
in july 2003, the company acquired wasatch product development, inc. for 5,016 in cash. in conjunction with the acquisition, certain liabilities were assumed, including 200 in income tax liabilities of the selling shareholders and 125 for professional fees directly associated with the acquisition.
in february 2004, the company acquired fmg productions, llc for 2,060 in cash. in conjunction with the acquisition, liabilities totaling 80 were assumed for professional fees directly associated with the acquisition.
net proceeds from the sale of common stock																																																																								271,000	222,000		291,000	954,000	1,378,000		129,000
benefit from inventory obsolescence																																																																									432,000				476,000			480,000	426,000
during the quarter ended april 3, 2004, the company acquired fmg productions, llc for 2,060 in cash. in conjunction with the acquisition, liabilities totaling 77 were assumed for professional fees directly associated with the acquisition.
changes in assets and liabilities:
income taxes receivable																																																																																		930,000	-169,000
prepaid expenses and other current assets
purchase of property and equipment
net proceeds from sale of common stock
common stock retired
restructuring provision
payments of capital lease obligations
effect of exchange rate changes on cash																																																																														497,000	-281,000
cash and cash equivalents beginning of year
cash and cash equivalents end of year
cash and cash equivalents beginning of period																																																																															0	0	2,465,000		0
cash and cash equivalents end of period																																																																															1,802,000	1,203,000	3,269,000		940,000
loss on restructuring and impairment
common stock retired and advances to related party
proceeds from the issuance of long-term debt
adjustments to reconcile net earnings to net cash provided by
operating activities
benefit from losses on receivables																																																																																			8,000
accounts receivable
non-cash operating activities
loss on sale and disposition of plant and equipment against the restructuring
and impairment provision
loss on sale and disposition of plant and equipment against the restructuring and impairment provision

We provide you with 20 years of cash flow statements for USANA Health Sciences stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of USANA Health Sciences stock. Explore the full financial landscape of USANA Health Sciences stock with our expertly curated income statements.

The information provided in this report about USANA Health Sciences stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.